Immunotherapy: Tisagenlecleucel - the first approved CAR-T-cell therapy: implications for payers and policy makers.
作者信息
Prasad Vinay
机构信息
Division of Hematology and Medical Oncology, Knight Cancer Institute; Department of Preventive Medicine and Public Health; and Center for Health Care Ethics, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, Oregon 97239, USA.
出版信息
Nat Rev Clin Oncol. 2018 Jan;15(1):11-12. doi: 10.1038/nrclinonc.2017.156. Epub 2017 Oct 4.
PMID:28975930
Abstract
摘要
Zotero 插件